ARTICLE | Company News
Ardana, Cytochemia AG sales and marketing update
June 20, 2005 7:00 AM UTC
ARA granted Cytochemia exclusive German marketing rights to Striant, a buccal testosterone replacement therapy to treat male hypogonadism. Cytochemia plans to launch Striant this year. ARA will rece...